Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Amira B. Kassem"'
Autor:
Amira B. Kassem, Ahmad Z. Al Meslamani, Dina H. Elmaghraby, Yosr Magdy, Mohamed AbdElrahman, Ahmed M.E. Hamdan, Hebatallah Ahmed Mohamed Moustafa
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Introduction Healthcare systems in developing countries faced significant challenges during COVID-19, grappling with limited resources and staffing shortages. Assessment of the impact of pharmaceutical care expertise, particularly in critical care un
Externí odkaz:
https://doaj.org/article/4075f9f47a854c5fb33b893b5744ae0a
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 12, Iss 1, Pp 1-10 (2023)
Abstract Background Since the first report of COVID-19 in 2019, information released has been fast and vast. Health literacy focuses on individual skills to obtain, process, and understand health information and services necessary to make informed he
Externí odkaz:
https://doaj.org/article/b87f5f0b44244c5ab1b7b367811f4761
Autor:
Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 12, Iss 1, Pp 1-19 (2023)
Abstract Inflammatory bowel disease (IBD) involves a variety of conditions, particularly Crohn’s disease (CD) and ulcerative colitis (UC). IBD is characterized by chronic inflammatory process of patient’s gut. This review aims to summarize the ph
Externí odkaz:
https://doaj.org/article/40e39aac79a5450183236c6ebedd0991
Autor:
Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 12, Iss 1, Pp 1-14 (2023)
Abstract Background Inflammatory Bowel disease (IBD) is a chronic progressive condition that prompts generous physical and mental morbidity. Choosing the best kind of management and medication dosage prevents new episodes of high disease activity dur
Externí odkaz:
https://doaj.org/article/65e851dc4cdd4571b91edc104458a025
Autor:
Rofida Albash, Rania Moataz El-Dahmy, Mohammed I. A. Hamed, Khaled M. Darwish, Abdulrahman M. Alahdal, Amira B. Kassem, Abdurrahman M. Fahmy
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2784-2795 (2022)
Levocetirizine hydrochloride (LVC) is an antihistaminic drug that is repurposed for the treatment of alopecia. This investigation is targeted for formulating LVC into cationic ceramide/phospholipid composite (CCPCs) for the management of alopecia. CC
Externí odkaz:
https://doaj.org/article/c7975c27b1a646248532a2f1ebcb5bc2
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 10, Pp 1090-1095 (2021)
Background: Medication errors are the errors that impact the efficacy and safety of the therapy. The impact of medication errors is higher for certain subjects, such as pediatrics, who require more attention. Hence, the current study aimed to investi
Externí odkaz:
https://doaj.org/article/cb78a2ca90cc49d0a2d0713273c0cc4d
Autor:
Manar A. Serageldin, Amira B. Kassem, Yasser El-Kerm, Maged W. Helmy, Mahmoud M. El-Mas, Noha A. El-Bassiouny
Publikováno v:
Drug Safety. 46:587-599
Autor:
Mahmoud El-Mas, Amira B. Kassem, Noha A. El-Bassiouny, Maged W. Helmy, Yasser El-Kerm, Manar A. Serageldin
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology.
Autor:
Yomna M El-Meligui, Naglaa M Hassan, Amira B Kassem, Nora A Gouda, Marwa Mohanad, Manal A Hamouda, Ahmad Salahuddin
Publikováno v:
Pharmacogenomics and Personalized Medicine. 15:663-674
Yomna M El-Meligui,1 Naglaa M Hassan,1 Amira B Kassem,2 Nora A Gouda,3 Marwa Mohanad,4 Manal A Hamouda,5 Ahmad Salahuddin6 1Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 2Clinical Pharmacy and Pharmacy Prac
Publikováno v:
Journal of Clinical and Nursing Research. 6:24-30
Background: Warfarin is widely regarded as the main anticoagulant in lowering the risk of thromboembolism. This study used indicators to compare pharmacist-managed anticoagulation services, using a well-prepared protocol, with physician-managed antic